1α,25-dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness

Molecular Endocrinology

Volumn 19, Issue 9, 2005, Pages 2349-2357

  Liu, Wei ^a   Asa, Sylvia L ^a,c,d   Ezzat, Shereen ^b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Department of Pathology ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; FIBRONECTIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SEOCALCITOL; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; VITAMIN D; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE;

ARTICLE; ATTENUATION; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER; WILD TYPE; XENOGRAFT; ANIMAL; CELL CULTURE; DRUG EFFECT; DRUG SCREENING; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; MUTATION; THYROID TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCITRIOL; CELL ADHESION; DOWN-REGULATION; FIBRONECTINS; HUMANS; MICE; MICE, SCID; MUTATION; RNA, SMALL INTERFERING; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 24344498565     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0117     Document Type: Article

References (44)

1. Asa SL, Bedard YC 2000 Fine-needle aspiration cytology and histopathology. In: Clark OH, Noguchi S, eds. Thyroid cancer. Diagnosis and treatment. St. Louis: Quality Medical Publishing, Inc.; 39-104
2. Fagin JA 1992 Genetic basis of endocrine disease 3. Molecular defects in thyroid gland neoplasia. J Clin Endocrinol Metab 75:1398-1400
3. Farid NR, Shi Y, Zou M 1994 Molecular basis of thyroid cancer. Endocr Rev 15:202-232
4. Fife RS, Sledge Jr GW, Proctor C 1997 Effects of vitamin D3 on proliferation of cancer cells in vitro. Cancer Lett 120:65-69
5. Kawa S, Nikaido T, Aoki Y, Zhai Y, Kumagai T, Furihata K, Fujii S, Kiyosawa Y 1997 Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer 76:884-889
6. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS 1999 1,25-Dihydroxychole-calciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res 59:2644-2649
7. 3 analog with an extensively modified side chain (CB1093). J Cell Biochem 70:414-424
8. 3 and its analogue, EB1089, in human breast cancer cells. Oncogene 15:1555-1563
9. KIP1. Blood 93:2225-2233
10. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM 1992 Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446-449
11. Liu W, Asa SL, Fantus IG, Walfish PG, Ezzat S 2002 Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/Akt-dependent and -independent pathways. Am J Pathol 160:511-519
12. Dackiw AP, Ezzat S, Huang P, Liu W, Asa SL 2004 Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer. Endocrinology 145:5840-5846
13. Conacci-Sorrell M, Zhurinsky J, Ben Ze'ev A 2002 The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109:987-991
14. Ryu S, Jimi S, Eura Y, Kato T, Takebayashi S 1999 Strong intracellular and negative peripheral expression of fibronectin in tumor cells contribute to invasion and metastasis in papillary thyroid carcinoma. Cancer Lett 146:103-109
15. Gehrmann ML, Douglas JT, Banyai L, Tordai H, Patthy L, Llinas M 2004 Modular autonomy, ligand specificity, and functional cooperativity of the three in-tandem fibronectin type II repeats from human matrix metalloproteinase 2. J Biol Chem 279:46921-46929
16. Franceschi RT, Linson CJ, Peter TC, Romano PR 1987 Regulation of cellular adhesion and fibronectin synthesis by 1α,25-dihydroxyvitamin D3. J Biol Chem 262:4165-4171
17. Mareel M, Leroy A 2003 Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83:337-376
18. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G 2001 β-Catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158:987-996
19. Ishigaki K, Namba H, Nakashima M, Nakayama T, Mitsutake N, Hayashi T, Maeda S, Ichinose M, Kanematsu T, Yamashita S 2002 Aberrant localization of β-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab 87:3433-3440
20. Suzuki S, Takenoshita S, Furukawa H, Tsuchiya A 1999 Antineoplastic activity of 1,25(OH)2D3 and its analogue 22-oxacalcitriol against human anaplastic thyroid carcinoma cell lines in vitro. Int J Mol Med 4:611-614
21. Danen EH, Yamada KM 2001 Fibronectin, integrins, and growth control. J Cell Physiol 189:1-13
22. Takei H, Iino Y, Horiguchi J, Yokoe T 1995 Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma. Oncology 52:106-111
23. Ryu S, Jimi S, Eura Y, Kato T, Takebayashi S 1998 Retention of intracellular fibronectin expression in primary and metastatic thyroid carcinoma: an immunohistochemical study. Cancer Lett 133:215-222
24. Ryu S, Jimi S, Takebayashi S 1997 Thyroid carcinoma distinctively expresses intracellular fibronectin in vivo. Cancer Lett 121:189-193
25. Polly P, Carlberg C, Eisman JA, Morrison NA 1996 Identification of a vitamin D3 response element in the fibronectin gene that is bound by a vitamin D3 receptor homodimer. J Cell Biochem 60:322-333
26. Akamatsu H, Ichihara-Tanaka K, Ozono K, Kamiike W, Matsuda H, Sekiguchi K 1996 Suppression of transformed phenotypes of human fibrosarcoma cells by overexpression of recombinant fibronectin. Cancer Res 56:4541-4546
27. Segaert S, Garmyn M, Degreef H, Bouillon R 1998 Anchorage-dependent expression of the vitamin D receptor in normal human keratinocytes. J Invest Dermatol 111:551-558
28. Kim SK, Su LK, Oh Y, Kemp BL, Hong WK, Mao L 1998 Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Oncogene 16:89-93
29. Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA 1997 MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221-5225
30. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP 1998 Pten is essential for embryonic development and tumour suppression. Nat Genet 19:348-355
31. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del BB, I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW 1998 High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8:1169-1178
32. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R 1999 Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96:1563-1568
33. Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C 1997 Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57:4710-4713
34. Halachmi N, Halachmi S, Evron E, Cairns P, Okami K, Saji M, Westra WH, Zeiger MA, Jen J, Sidransky D 1998 Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer 23:239-243
35. Gimm O, Perren A, Weng LP, Marsh DJ, Yeh JJ, Ziebold U, Gil E, Hinze R, Delbridge L, Lees JA, Mutter GL, Robinson BG, Komminoth P, Dralle H, Eng C 2000 Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol 156:1693-1700
36. Weng LP, Gimm O, Kum JB, Smith WM, Zhou XP, Wynford-Thomas D, Leone G, Eng C 2001 Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Hum Mol Genet 10:251-258
37. Bruni P, Boccia A, Baldassarre G, Trapasso F, Santoro M, Chiappetta G, Fusco A, Viglietto G 2000 PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Oncogene 19:3146-3155
38. Liu W, Asa SL, Ezzat S 2002 Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells. Brain Pathol 12:412-419
39. Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssila K, Joensuu H 2003 Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res 9:68-75
40. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, de la Chapelle A 2001 Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98:15044-15049
41. Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, Chapelle AL, Kloos RT 2005 Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 18:48-57
42. Takano T, Miyauchi A, Matsuzuka F, Kuma K, Amino N 2000 Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: a possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas. J Clin Endocrinol Metab 85:765-768
43. Perez-Fernandez R, Alonso M, Segura C, Munoz I, Garcia-Caballero T, Diguez C 1997 Vitamin D receptor gene expression in human pituitary gland. Life Sci 60:35-42
44. Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk GJ, Giese K, Kaufmann J 2003 Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 31:2705-2716